Zobrazeno 1 - 10
of 52
pro vyhledávání: '"Andrew E. Nixon"'
Autor:
Yvett Sosa, Bhav Kapur, Jessica Hurtak, Laura J. Kingsley, Hao Wu, Stefanie Gruber, Herbert Nar, Saad Khattabi, Jesus Seco Moral, Maria Fátima Lucas, Caterina Martin, Nikola Lončar, Frederic Buono, Noah Pefaur, Andrew E. Nixon, Jinhua J. Song
Publikováno v:
Frontiers in Chemical Biology, Vol 3 (2024)
Introduction: Biocatalysis, particularly through engineered enzymes, presents a cost-effective, efficient, and eco-friendly approach to compound synthesis. We sought to identify ketoreductases capable of synthesizing optically pure alcohols or ketone
Externí odkaz:
https://doaj.org/article/9cf8af4a995a453ca62582f81e558283
Autor:
Joschka Bauer, Nandhini Rajagopal, Priyanka Gupta, Pankaj Gupta, Andrew E. Nixon, Sandeep Kumar
Publikováno v:
Frontiers in Molecular Biosciences, Vol 10 (2023)
Antibody-based biotherapeutics have emerged as a successful class of pharmaceuticals despite significant challenges and risks to their discovery and development. This review discusses the most frequently encountered hurdles in the research and develo
Externí odkaz:
https://doaj.org/article/7cdbcabaecc84b5eabb91c988ce1f033
Autor:
Yanyun Liu, Kenny Tsang, Michelle Mays, Gale Hansen, Jeffrey Chiecko, Maureen Crames, Yangjie Wei, Weijie Zhou, Chase Fredrick, James Hu, Dongmei Liu, Douglas Gebhard, Zhong-Fu Huang, Akshita Datar, Anthony Kronkaitis, Kristina Gueneva-Boucheva, Daniel Seeliger, Fei Han, Saurabh Sen, Srinath Kasturirangan, Justin M. Scheer, Andrew E. Nixon, Tadas Panavas, Michael S. Marlow, Sandeep Kumar
Publikováno v:
mAbs, Vol 14, Iss 1 (2022)
Biotherapeutic optimization, whether to improve general properties or to engineer specific attributes, is a time-consuming process with uncertain outcomes. Conversely, Consensus Protein Design has been shown to be a viable approach to enhance protein
Externí odkaz:
https://doaj.org/article/4c91351f25cc410584aa768aeb4853a4
Publikováno v:
Antibodies, Vol 9, Iss 4, p 65 (2020)
T-cell Engaging bispecific antibodies (TcEs) that can re-direct cytotoxic T-cells to kill cancer cells have been validated in clinical studies. To date, the clinical success with these agents has mainly been seen in hematologic tumor indications. How
Externí odkaz:
https://doaj.org/article/e2d56adc7fe64fd6a72748680d8fff3e
Autor:
Paul J. Adam, Justin M. Scheer, Andrew E. Nixon, Francesca Trapani, Craig Giragossian, Barbara Drobits-Handl, Vladimir Voynov, Susanne Hipp
Purpose:Small cell lung cancer (SCLC) is the most lethal and aggressive subtype of lung carcinoma characterized by highly chemotherapy-resistant recurrence in the majority of patients. To effectively treat SCLC, we have developed a unique and novel I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3ec8681e88494e3f0566fefc32aeffd
https://doi.org/10.1158/1078-0432.c.6529409
https://doi.org/10.1158/1078-0432.c.6529409
Autor:
Paul J. Adam, Justin M. Scheer, Andrew E. Nixon, Francesca Trapani, Craig Giragossian, Barbara Drobits-Handl, Vladimir Voynov, Susanne Hipp
Supplementary Tables and Figures
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::877e80c7cc7e540b5a06c9860c65722a
https://doi.org/10.1158/1078-0432.22476485.v1
https://doi.org/10.1158/1078-0432.22476485.v1
Autor:
Daniel T. Dransfield, Clive R. Wood, Maria Luisa Valentino, Shafaat A. Rabbani, Chris TenHoor, Paula Henderikx, Rene Hoet, Robert C. Ladner, Andrew E. Nixon, Sonia Schoonbroodt, Yu Lu Ma, Csaba Pazmany, Shannon Hogan, Douglas Rank, Guannan Kuang, Daniel J. Sexton, Reinoud van Gool, Annabelle Lejeune, Marc Vanhove, Qingfeng Tao, Edward Chang, Nicolas Frans, Henk Pieters, Niranjan Yanamandra, Laurent Naa, Lili Huang, Laetitia Devy
Inhibition of specific matrix metalloproteinases (MMP) is an attractive noncytotoxic approach to cancer therapy. MMP-14, a membrane-bound zinc endopeptidase, has been proposed to play a central role in tumor growth, invasion, and neovascularization.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5ad90f85bac4e1357eb214667eadf37f
https://doi.org/10.1158/0008-5472.c.6499896.v1
https://doi.org/10.1158/0008-5472.c.6499896.v1
Autor:
Daniel T. Dransfield, Clive R. Wood, Maria Luisa Valentino, Shafaat A. Rabbani, Chris TenHoor, Paula Henderikx, Rene Hoet, Robert C. Ladner, Andrew E. Nixon, Sonia Schoonbroodt, Yu Lu Ma, Csaba Pazmany, Shannon Hogan, Douglas Rank, Guannan Kuang, Daniel J. Sexton, Reinoud van Gool, Annabelle Lejeune, Marc Vanhove, Qingfeng Tao, Edward Chang, Nicolas Frans, Henk Pieters, Niranjan Yanamandra, Laurent Naa, Lili Huang, Laetitia Devy
Supplementary Methods and Materials from Selective Inhibition of Matrix Metalloproteinase-14 Blocks Tumor Growth, Invasion, and Angiogenesis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::362235aff74f4e94e6209bb11bdd0a07
https://doi.org/10.1158/0008-5472.22381518.v1
https://doi.org/10.1158/0008-5472.22381518.v1
Autor:
Daniel T. Dransfield, Clive R. Wood, Maria Luisa Valentino, Shafaat A. Rabbani, Chris TenHoor, Paula Henderikx, Rene Hoet, Robert C. Ladner, Andrew E. Nixon, Sonia Schoonbroodt, Yu Lu Ma, Csaba Pazmany, Shannon Hogan, Douglas Rank, Guannan Kuang, Daniel J. Sexton, Reinoud van Gool, Annabelle Lejeune, Marc Vanhove, Qingfeng Tao, Edward Chang, Nicolas Frans, Henk Pieters, Niranjan Yanamandra, Laurent Naa, Lili Huang, Laetitia Devy
Supplementary Tables1-2 from Selective Inhibition of Matrix Metalloproteinase-14 Blocks Tumor Growth, Invasion, and Angiogenesis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::202e975447b6fb0d17af004056b1b698
https://doi.org/10.1158/0008-5472.22381515
https://doi.org/10.1158/0008-5472.22381515
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America
Significance Successful biologic drug discovery and development involves finding functional as well as developable candidates. Once a candidate has been demonstrated to be functional, the next step is to determine whether it can be translated into a